Oxybutynin Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01062 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 17 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | restless legs syndrome | KG + DL |
| 2 | gastroduodenitis | KG + DL |
| 3 | peptic ulcer disease | KG + DL |
| 4 | low compliance bladder | KG + DL |
| 5 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 6 | insomnia (disease) | KG + DL |
| 7 | attention deficit-hyperactivity disorder | KG + DL |
| 8 | faciodigitogenital syndrome | KG + DL |
| 9 | familial episodic pain syndrome with predominantly upper body involvement | KG + DL |
| 10 | transient tic disorder | KG + DL |
| 11 | migraine disorder | KG + DL |
| 12 | migraine with brainstem aura | KG + DL |
| 13 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 14 | communication disorder | KG + DL |
| 15 | stereotypic movement disorder | KG + DL |
| 16 | fetal nicotine spectrum disorder | KG + DL |
| 17 | developmental disorder of mental health | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.